Elanco Animal Health Incorporated has closed the acquisition of Bayer Animal Health. The $6.89-billion transaction brings over 166 years of legacy between the companies, said Jeff Simmons, president and CEO of Elanco.
Genomic editing technology such as CRISPR/Cas9 offers tremendous potential for accelerating genetic progress, but a new ruling from the European Court of Justice (ECJ) appears likely to stifle research and development.
One lesson COVID-19 has taught our country is agriculture is essential. “We can't replace people getting up and doing the chores," says Dan Thomson, chair of the Department of Animal Science at Iowa State University.
Farm Journal Field Days offers a packed three-day agenda, as well as some other great show elements for you to enjoy, including the #FarmON Benefit Concert, beer garden sessions, virtual expo hall and more!
As methods and applications for biotechnology in agriculture continue to advance at a rapid pace, regulators work to maintain a balance between safety and potentially rapid progress in food production.
In Chillicothe, Ohio Jacob Shuman works hard every day to maintain his honeybee hives and teach other students about the insect. With bee populations on the decline, education and healthy hives have become important.